Smithfield Trust’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY.RT
JCI
BC
TNB
WAM
IAIM
Smithfield Trust's BMY.RT Position: Q1 2021 in Review
Smithfield Trust sold out of Bristol-Myers Squibb Company Contingent Value Rights (BMY.RT) in Q1 2021, closing a stake of 490 shares.
Smithfield Trust first reported a position in BMY.RT in Q4 2019 and held it in 4 quarters. The position peaked at $1K in Q3 2020. 12 funds tracked by Wall St. Rank hold BMY.RT as of Q1 2021.
- Smithfield Trust reported no remaining Bristol-Myers Squibb Company Contingent Value Rights position as of Q1 2021 after selling out during the quarter.
- Smithfield Trust sold 490 Bristol-Myers Squibb Company Contingent Value Rights shares in Q1 2021.
- Smithfield Trust first reported a position in Bristol-Myers Squibb Company Contingent Value Rights in Q4 2019 and held it in 4 quarters.
- Smithfield Trust's Bristol-Myers Squibb Company Contingent Value Rights position peaked at $1K in Q3 2020.
- 12 funds tracked by Wall St. Rank held Bristol-Myers Squibb Company Contingent Value Rights as of Q1 2021.
Based on Smithfield Trust's 13F filing for Q1 2021, filed 14 May 2021.